WO2002096940A3 - Virus attenue de la bursite infectieuse des volailles tres virulente - Google Patents

Virus attenue de la bursite infectieuse des volailles tres virulente Download PDF

Info

Publication number
WO2002096940A3
WO2002096940A3 PCT/NL2002/000353 NL0200353W WO02096940A3 WO 2002096940 A3 WO2002096940 A3 WO 2002096940A3 NL 0200353 W NL0200353 W NL 0200353W WO 02096940 A3 WO02096940 A3 WO 02096940A3
Authority
WO
WIPO (PCT)
Prior art keywords
attenuated
disease virus
bursal disease
infectious bursal
virulent infectious
Prior art date
Application number
PCT/NL2002/000353
Other languages
English (en)
Other versions
WO2002096940A2 (fr
Inventor
Hendrik Johannis Boot
Original Assignee
Id Lelystad Inst Dierhouderij
Hendrik Johannis Boot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Lelystad Inst Dierhouderij, Hendrik Johannis Boot filed Critical Id Lelystad Inst Dierhouderij
Priority to AU2002314610A priority Critical patent/AU2002314610A1/en
Publication of WO2002096940A2 publication Critical patent/WO2002096940A2/fr
Publication of WO2002096940A3 publication Critical patent/WO2002096940A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10061—Methods of inactivation or attenuation
    • C12N2720/10064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne le domaine de la prévention ou du traitement d'infections dues au virus de la bursite infectieuse des volailles. L'invention concerne une méthode de production de vvIBDV atténué et de vaccins basés sur celui-ci par une modification de la séquence primaire d'une région essentiellement non traduite de l'acide nucléique viral.
PCT/NL2002/000353 2001-05-31 2002-05-31 Virus attenue de la bursite infectieuse des volailles tres virulente WO2002096940A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002314610A AU2002314610A1 (en) 2001-05-31 2002-05-31 Attenuated very virulent infectious bursal disease virus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202079.8 2001-05-31
EP01202079 2001-05-31

Publications (2)

Publication Number Publication Date
WO2002096940A2 WO2002096940A2 (fr) 2002-12-05
WO2002096940A3 true WO2002096940A3 (fr) 2003-12-11

Family

ID=8180403

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2002/000353 WO2002096940A2 (fr) 2001-05-31 2002-05-31 Virus attenue de la bursite infectieuse des volailles tres virulente

Country Status (2)

Country Link
AU (1) AU2002314610A1 (fr)
WO (1) WO2002096940A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049077A2 (fr) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Vaccin aviaire efficace contre le virus de la bursite infectieuse aviaire
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1069187A1 (fr) * 1999-07-14 2001-01-17 Stichting Dienst Landbouwkundig Onderzoek Vaccin contenent un virus mosaique de la maladie infectieuse des bourses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1069187A1 (fr) * 1999-07-14 2001-01-17 Stichting Dienst Landbouwkundig Onderzoek Vaccin contenent un virus mosaique de la maladie infectieuse des bourses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOOT HEIN J ET AL: "Efficient rescue of infectious bursal disease virus from cloned cDNA: Evidence for involvement of the 3'-terminal sequence in genome replication.", VIROLOGY, vol. 265, no. 2, 20 December 1999 (1999-12-20), pages 330 - 341, XP002186284, ISSN: 0042-6822 *
NAGARAJAN MALLIGA M ET AL: "Selection of an infectious bursal disease virus mutant with increased immunogenicity following passage under humoral immune pressure.", CANADIAN JOURNAL OF VETERINARY RESEARCH, vol. 65, no. 2, April 2001 (2001-04-01), pages 89 - 96, XP001041885, ISSN: 0830-9000 *
WEBER SIEGFRIED ET AL: "Expression of VP5 of infectious pancreatic necrosis virus strain VR299 is initiated at the second in-frame start codon.", JOURNAL OF GENERAL VIROLOGY, vol. 82, no. 4, April 2001 (2001-04-01), pages 805 - 812, XP002186285, ISSN: 0022-1317 *

Also Published As

Publication number Publication date
WO2002096940A2 (fr) 2002-12-05
AU2002314610A1 (en) 2002-12-09

Similar Documents

Publication Publication Date Title
WO2004112831A3 (fr) Virus influenza de recombinaison a titre eleve pour vaccins et therapie genique
WO2007002470A3 (fr) Vaccins chimeres inactives et leurs procedes d'utilisation
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
ATE396739T1 (de) Entwicklung einer vakzine zur prävention von infektionen mit filovirus bei primaten
WO2008009652A3 (fr) Vaccins contre le paludisme
WO2004045529A3 (fr) Vaccin contre le virus du nil occidental
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
WO2005004910A3 (fr) Vaccins contre le virus de l'hepatite c
MXPA03000061A (es) Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos.
WO2002013855A3 (fr) Vaccins contenant de la ribavirine et procedes d'utilisation associes
WO2003023040A3 (fr) Mutants du virus de la vaccine obtenus par inactivation de mva-e3l et leur utilisation
WO2006041978A3 (fr) Vaccins polyvalents contre la grippe aviaire
AU2003288510A1 (en) Immunizing fish against viral infection
JP2006512078A5 (fr)
WO2007121491A8 (fr) Vaccinations contre le hcv
WO2004091524A3 (fr) Vaccins contre des virus des voies respiratoires
EP1749885B8 (fr) Vaccin infectieux et attenues du virus de la diarrhée virale bovine
DE69533067D1 (de) Hepatis e-virus antigene und dessen verwendungen
WO2006024240A3 (fr) Composition vaccinale contre le virus de l'hepatite c
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
WO2003053332A3 (fr) Composition et procede pour le traitement d'une infection virale
WO2002096940A3 (fr) Virus attenue de la bursite infectieuse des volailles tres virulente
WO2003037265A3 (fr) Methode de traitement d'infections virales
CA2363493A1 (fr) Virus de la diarrhee virale bovine de formes attenuees
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP